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To investigate whether Langerhans cells are capable of in-
ducing contact sensitivity effector T cells, we incubated puri-
fied T cells from naive mice with syngeneic cultured trini-
trophenyl-modified Langerhans cells for 4 - 5 d. The cells 
were then expanded in interleukin-2 and fresh medium for 
another 6 - 9 d and injected intravenously into naive syngen-
eic recipient mice. After the ears of recipient mice were 
painted with 1 % trinitrochlorobenzene, we observed an ear-
swelling response peaking at 24 - 48 h. The ear-swelling re-
sponse was hapten specific. C08- but not C04-depleted T 
cells mediated strong contact sensitivity. Systemic adoptive 
C ontact sensitivity (CS) is a cell-mediated inflamma-tory response of delayed onset (27 - 72 h) to the epi-cutaneous application of some highly reactive simple chemical compounds (haptens). In mice, CS can be induced by a single application of compounds such as 
dinitrochlorobenzene, trinitrochlorobenzene (TNCB), or oxazo-
lone. The inductive phase of CS has extensively been studied in the 
last few years and Langerhans cells (LC) - major histocompatibility 
complex (MHe) class II positive, intraepidermal dendritic antigen-
presenting cells (APe) -are thought to playa crucial role in this 
reaction. 
These conclusions are drawn from a large number of experiments 
performed by different groups of investigators. In one kind of ex-
periment, the failure to induce CS by application of haptens to 
LC-deficient skin (tai l skin, hamster cheek pouch) or skin with 
altered LC ultraviolet B [UVB]- or glucocorticoid-treated skin) was 
taken as evidence for the role of LC in the induction of CS [1 - 4]. 
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transfer into nude mice also lead to a hapten-specific delayed 
ear-swelling response. However, this response was less prO-
tracted than in euthymic animals, suggesting the participa-
tion of the recipient (non-immunized) T cells in the ear-
swelling response of the euthymic mice. Lymphokine 
analysis of in vitro primed and restimulated T cells revealed 
predominant production of interleukin-2 but little or no in-
terleukin-4. These in vitro primed cells therefore resemble 
type 1 or inflammatory T helper cell clones.] Invest Damatol 
95:436-440,1990 
The latter experiments seemed particularly conclusive because a 
phenotypic alteration of LC was associated with the failure to in-
duce CS . In another line of experiments, hapten-modified LC-con-
taining epidermal cells or LC-enriched epidermal cells were in-
jected into naive animals. The successful immunization of rnest 
animals was taken as further evidence for the critical role of LC for 
the induction of CS [5 - 7) .  The failure to induce CS with LC-ddi-
cient epidermal cells underlined the significance of these e».-peri-
ments. 
However, other experimental data speak against a major role Q ' 
LC in the induction of CS. It was found that low-dose UYE impain 
the induction of CS only in some mouse strains [8]. The susceptibil-
ity to low-dose UVE was later shown to be controlled by multiplt 
genetic loci [9]. In addition, a decrease in LC markers after 10w-dOst 
UVB was observed in UVB non-suspceptible strains [10]. Experi. 
ments with high-dose UV irradiation [11-14J were not conclusive 
for a role ofLC in CS, because this treatment led to immunosuppres-
sion, which was accompanied by a systemic defect of APC function. 
Furthermore, it was found that guinea pigs were sensitized to hap-
ten through tape-stripped skin, i.e., skin with decreased LC density 
[15). In the guinea pig system, injection of hapten-modified L 
reportedly failed to sensitize the animals [16), whereas injection 
hapten-modified peritoneal exudate cells and LC-depleted epider. 
mal cells successfully induced CS [16,17]. Finally, the recent report 
that the injection into naive mice of harten-modified dermal MH 
class II+ cells is capable of inducing CS 18] leaves open the possibil-
ity that skin-derived dermal APC but not epidermal LC could ~ 
responsible for the induction of CS by the transplantation of hap-
ten-modified skin [19]. 
To investigate whether LC can give rise to CS effector celJs, " 
set up an in vitro system that would produce CS effector cells usin" 
hapten-modified syngeneic cultured LC (cLe). Since Moorh~ 
demonstrated that T cells are capable of transfering CS [20], we t 
advantage of an earlier described in vitro system that allows the '. 
vitro generation of T cells with desired specificity from T cell ' 
non-immunized animals [21]. In this paper, we report on the -. 
cessful expression of CS by the systemic transfer of T-cell popu! 
tions that were cultured with hapten-modified cleo 
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MATERIALS AND METHODS 
LC-T Cell Cultures cLC were prepared and hapten modined as 
previously described [21 J. The cell suspension contained 30 - 50% 
cLC as assessed by fluorescent microscopy and flow cytometry using 
antibodies to MHC class II determinants. The remaining cells were 
mainly keratinocytes [21,30J. T cells were prepared by passing 
splenocytes and lymph node cells of non-immunized female Balb/c 
mice over nylon wool columns. The cells were then incubated with 
either anti-class II monoclonal antibody (MoAb) (M5/114.15.2, 
ATCC, Rockville, MD) or anti-class II plus either anti-CD4 
MoAb (GK 1.5, ATCC) or anti-COB MoAb (53-6.72, ATCC) for 
30 min on ice. The washed cells were subsequently incubated for 45 
min with low toxic rabbit complement (1: 10, Cedarlane, Hornby, 
Ontario, Canada) and a mouse MoAb to rat immunoglobulin kappa 
chain (MAR 18.5, ATCC). The purified T cells were cultured with 
hap.ten-modined cLC at a ratio of about 100 T cells to 1 cLC at 
?/r c in a humidified atmosphere. The culture media consisted of 
RPM11640 or Iscove's modified Dulbecco's medium supplemented 
with FCS (10%), penicillin (100IU/ml), streptomycin 
(100 j.lg/ml), glutamine (2mM), 2-mercaptoethanol (2 X 10-5 M, 
all from GIBCO, Basel, Switzerland). After 4- 5 d of culture fresh 
media containing 50 U /ml recombinant human interleukin-2 
(Cetus, Emeryville, CA) were added. The cultures were fed with 
fresh media and IL-2 every 2-3 d. After 11-13 d, the cells were 
washed and prepared either for adoptive transfer or in vitro restimu-
Wion. For in vitro restimulation, 0.5 X 106 T cells, that had been 
stnSitized with trinitrophenyl (TNP)-modified cLC, were incu-
bated for 2 - 3 d with lOS TNP-modified cLC. The resulting culture 
ropematant was then tested for lymphokine activity . 
Freshly prepared cells were analyzed by flow cytometry using 
Guorochrome-conjugated MoAb to CD4 and CDB (Becton Dick-
inson, Mountainview, CA). Cultured cells were stained with the 
same MoAb and 1000 cells scored by fluorescent light microscopy. 
r,ymphokine Assay [22] To obtain a measure for IL-2 and inter-
/cukin-4 (IL-4) production, Iymphokine-containing T helper cell 
culture supernatants were incubated in serial dilutions with CTLL 
cells, a kind gift of Dr. E.M. Shevach (LI, NIAID, NIH). These 
CTLL cells respond to both IL-2 and IL-4. To these cultures either 
S4B6 [23J, a neutralizing MoAb to mouse IL-2 (kindly provided by 
{)r.T . Mosmann, DNAX, Palo Alto, CA), !lIBll [24J, a neutraliz-
ing MoAb to mouse IL-4 (kindly provided by Dr. W.E. Paul, LI, 
NIAlD, NIH), both MoAb or no antibody were added. Internal 
5Undards for IL-2 and IL-4 were incubated in parallel. Proliferation 
fJas assessed by 3H-methyl-thymidine incorporation after pulsing 
me cultures (0.5 tiCi/well) for the final 6-8 h of the 24 h culture 
period. 
Transfer Experiments 5 X 107 in vitro sensitized T cells were 
resuspended in Hank's balanced salt solution (108 cells/ml) and 10 
U/mJ heparin. The cells were then injecred intravenously through 
the lateral tail vein or the retro-orbital venous plexus. The ears of 
the animals were immediately painted with 1 % TNCB (Poly-
~nces, Warrington, PA; in olive oil) or 0.5% fTuorescein.isothio-
cyanate (FITC) (Sigma, St. Louis, MO, in acetone/dibutyl-phrha-
Iuc, 1 : 1). After the indicated time period following transfer, ear 
thickness was assessed by an ear caliper (Interapid, Rolle, Switzer-
Iznd). Results are expressed as follows: ear swelling (mm X 
t(J-2) = ear thickness after transfer (mm X 10-2) minus ear thick-
ntSS before transfer (mm X 10-2). In some experiments, the 
rt/evant hapten was painted on one ear and the control hapten was 
painted on the other ear of the same animal. Significance levels were 
akulated using the Wilcoxon-Mann-Whitney rank sum test. 
RESULTS 
r Cells Sensitized In Vitro with eLC Mediate CS in N on-Im-
munized Recipient Mice T cells from non-immunized mice 
1lJ)Sirized in vitro with hapten-modified cLC and expanded in vitro 
with IL-2 were injected intravenously into two groups of syngeneic 
lIOIl-immunized recipient mice (5 X 107 cells per animal). One 
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Figure 1. Ear-swelling response of mice receiving T cells sensitized in vitro 
to TNP. T cells (5 X 107 cells per animal) from non-immunized Balblc 
mice sensitized in vitro with cultured TNP-modilied syngeneic cLC were 
injected into non-immunized syngeneic mice. Ears were immediately chal-
lenged with either TNCB or FITC and ear-sweIling responses assessed after 
the indicated time period. (solid circle) TNCB challenged mice (n = 4); (opetl 
circle) FITC challenged mice (n = 4); all p < 0.01 between 24 and 96 h. 
Error bars, .1 SEM. 
group was immediately challenged with the hapten used for in vitro 
sensitization and the other grOl1p was painted with an irrelevant 
hapten. The group of mice challenged with the homologous hapten 
TNCB developed delayed ear swelling peaking at 48 h (Fig 1). The 
group of mice receiving the irrelevant hapten FITC did not show 
'lny signincant ear swelling. Similarly, a delayed ear-swelling re-
sponse to FITC challenge was observed when the T cells were 
sensitized in vitro with FITC-modified cLC (data not shown) . Mice 
receiving 2 X 107 cells sensitized with TNP-modined cLC and 
challenged with TNCB did not show any significant ear swelling. 
These experiments demonstrate that hapten-specific CS-mediating 
T-cell populations-can be generated-by-cultnrirrg-hapten~m0dined ~ 
cLC with syngeneic non-immunized T cells. 
CD4+ T Cells Confer' CS In Vivo After In Vitro Activation 
with eLC In order to find out whether CD4+ or CD8+ T cells are 
capable of conferring CS in vivo after primary in vitro activation 
with hapten-modified cLC and subsequent expansion, we treated 
the freshly isolated T cells with MoAb to either CD4 (GK 1.5) or 
CD8 (53-6.72), followed by mouse anti-rat immunoglobulin 
MoAb (MAR 18.5) and complement. The cells were then sensitized 
in vitro, expanded, and finally injected into recipient mice. Data in 
Fig 2 show clearly that CD8-depleted T cells conferred CS in vivo. 
This suggests that CD4+ T cells were responsible for the transfer of 
CS, although a contribution from CD4-CD8- cells cannot be 
excluded. Little or no CS was elicited in mice receiving in vitro 
activated and expanded CD4-depleted T cells (Fig 2). Aliquots of 
cells from experiment 2 were analyzed by immunofluorescence mi-
croscopy before transfer. The CD4-depleted cell fraction contained 
3.0% CD4+ cells, the CD8--depleted fraction less than 3% CD8+ 
cells. Experiments with depletion of CD4+ or CDB+ cells after in 
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Figure 2. Ear-swelling responses of mice receiving either CD8- or CD4-
depleted T cells sensitized to TNP. RaIble T cells depleted of CD8+ or 
CD4+ cells and sensitized in vitro with TNP-modified cLC were injected 
into naive Balb/c mice and immediately challenged with TNCB on the 
right ear and with FrTC on the left ear. Peak ear-swelling responses are 
shown. Group 1, n = 2; group 2, n = 4; group 3, n = 8; group 4, n = 7; 
group 5, n = 7. TNCB induced ear-swelling responses: group 2 vs 3, P < 
0.01 ; group 4 vs 5, P < 0.001. Error bars, 1 SEM. 
Transferred CS Effector T Cells Recruit Recipient T Cells 
for the Elicitation Reaction When we transferred in vitro sen-
sitized CD8-depleted T cells into syngeneic nude recipients, an 
ear-swelling response was observed (Fig 3). At 24 h, the ear-swel-
ling response was weaker than in euthymic mice. At 48 h, the 
response of nude mice was near background, whereas the euthymic 
mice showed maximal response. No significanc ear swelling was 
observed in nude mice that were challenged with TNCB but did not 
receive any cells (data not shown) . These findings demonstrate that 
the 24-h ear-swelling response is partially independent of recipient 
T cells, but that the 48-h response in normal Balb/c mice depends 
on non-immune T cells of the recipient animal. 
In Vitro Sensitized CD8-Depleted T Cells Produce IL-2 
After In Vitro Restimulation To investigate whether in vitro 
sensitized CD8-depleted T cells produce IL-2 or IL-4, we restimu-
lated th ese cells in vitro with hapten-modified cLC. The culture 
supernatant was removed after 3 d and tested on CTLL cells, which 
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Figure 3. Ear-swelling responses of nude Or euthymic BalbI c nUce receiv-
ing CDS-depleted T cells s\!nsitized to TNP. Balb/e T cells depleted of 
CDS+ cel ls and sensitized in vitro to TNP were injected into naive nude 
(n = 5) or euthymic (n = 4) Balb/c mice. The animals were immediately 
challenged with TNBC on the right ear and with FITC on the left ear. 
Ear-swelling responses were assessed at 24 and 48 h. TNCB induced ear-
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Figure 4: Specific bioassay for IL-2 and IL-4 of culture supernatants frem in 
vitro restimulated CD8-depleted T cells mediating CS in vivo. CD8-d~ 
pleted T cells sensitized in vitro to TNP and which conferred CS in vi 
were restimulated in vitro with TNP-modified cLC. The 3-d culture super_ 
natant was filtered and incubated with CTLL cells that respond to both Il. 
and IL-4 . T ests were c arried out in the presence of MoAb to IL-2 (tria llgl~ 
S4B6) and to 1L-4 (rnverted tnallgle, llBl1), both With (star) or withOut 
MoAb (open circle). 3H-ineorporacion was assessed after 24 h and a labelin 
period of S h. Concanavalin A-stimulated spleen cell supernatant (ConK 
SN) and supernatant of X 63/0 cells transfected with a plasmid containin 
the mouse 1L-4 gene ([48]; X 63/0 SN) were used as internal IL-2 and Il~ 
standards, respectively. 
respond to both IL-2 and IL-4. The CTLL-growth - promotin 
activity contained in the culture supernatant was inhibited by ~ 
MoAb to IL-2 (S4B6) but not by a MoAb to IL-4 (1IBll) (Fig 4). 
Furthermore, culture supernatants to which both MoAb had been 
added showed the same activity as culture supernatants to which 
only anti-IL-2 MoAb were added. In other experiments (data no 
shown), small amounts of IL-4 were detected in the culture super. 
natants using the same assay. Experiments in which anti-IL-2 and 
anti- IL-4 antibodies were directly added to in vitro sensitiz 
CD8-depleted T cells and TNP-modified cLC showed inhibitiol\ 
with the antibody to IL-2 but no significant inhibition with the 
antibody to IL-4 (data not shown). These results suggest that the 1: 
cells restimulated · in vitro with hapten-modified cLC produc 
mainly IL-2 and little or no IL-4. 
DISCUSSION 
Our results give the first direct evidence for the ability of cLC l\) 
induce CS effector T cells in an adoptive transfer system. In contrast 
to the system described here, the APC was poorly defined in fonnet 
studies on the induction of DTH effector cells in vitro [25,26]. The 
in vitro induction protocol for CS effector cells described by Kn P 
and colleagues [27,28) used bone marrow -derived plastic adherent 
cells grown in CSF-l containing medium. It is not excluded that 
these cultures contained small amounts of dendritic cells. Lymphoi 
dendritic cells are considered to be the APC of primary T-cell re-
sponses [29J. cLC and lympoid dendritic cells share the functional 
ac tivity of being potent for primary T-cell responses. Althou h 
dendritic cells are capable of activating primary TNP-dependent 
T-cell proliferation [30J, we do not know whether they are capabl 
of inducing CS effector T cells in the described system. We ha, 
previously used cLC to produce hapten-, al1o-, and protein-
antigen-specific CD4+ T-cell lines [21 ,22) . These cell lines Wen' 
produced by repetitive stimulation with cLC and secreted IL- . 
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IL-4 - producing cell lines, however, were reported not to mediate 
delayed-type hypersensitivity [31]. We were unable to grow our 
hapten-specific IL-4 producing lines up to cell numbers (5 X 107 
per animal) necessary for an adoptive transfer. We did not test 
freshly isolated LC, because these cells bear a low class II density in 
our hands and die quickly in cell culture [32,33] . However, in epi-
dermal cell culture, LC increase their class II density and become 
potent APC [32- 34]. Granulocyte-macrophage colony-stimulat-
ing factor together with IL-l, which are both produced by keratino-
cytes (more than 90% of freshly isolated epidermal cells) in culture, 
can induce these changes in highly purified fresh LC [35,36]. Our 
data show that cLC can trigger the generation of CS effector cells 
but a role for LC in the induction of CS in vivo has not yet been 
directl y demonstrated, although it is most probable. LC are thought 
to migrate via lymphatic vessels to the paracortical T-cell areas of 
the regional lymph nodes after hapten exposure in the epidermis. 
Indeed, FITC-bearing, dendritically shaped class II+ cells have been 
observed in the lymph node 24 h after skin painting with FITC [37] . 
These cells are capable of inducing CS in naive recipients, stimulate 
the proliferation of non-sensitized T cells, bear the dendritic cell 
marker 33Dl, and contain Birbeck granules [37 -40]. However, 
their identity with or their derivation from LC remains unproved. 
Additionall y, it is possible that dermis-derived cells might also func-
tion as APC for the induction of CS. 
Transfer experiments revealed that CD8-depleted T cells were 
responsible for the elicitation of CS in the recipients. The CS re-
sponse peaked at 24-48 h (Fig 1). However, persistent ear swelling 
was found up to 6 d. It is possible that the swelling measured after 48 
co 72 h was due to concomitant transfer of hapten-modified cLC 
still present in the IL-2-expanded T-cell preparation. Injection of 
hapten-modified LC has been shown to induce delayed ear-swelling 
responses upon challenging after 5 d [7J. However, the earlier 24-
48 h ear-swelling responses cannot be explained by transfer of T 
cells contaminated with hapten-modified cLC. Our data are in ac-
cordance with other experimental systems showing that the elicita-
tion of CS is dependent on CD4+ T cells [41]. CD4-depleted T cells 
which were sensitized in vitro did not confer strong CS in vivo 
in our system. It has, however, recently been shown that CD8+ T 
cells playa role in vivo as CS effector cells [42]. It is therefore 
possible that the cells generated in vitro are functiona lly different 
from those generated in vivo and that they might need additional 
factors and/or cells to become functional in vivo. The fact that, for 
technical reasons, we used lymph nodes and spleens (instead of 
solely lymph nodes draining the skin) to prepare the large 
amounts of T cells (2 -4 X 108 cells per experiment) needed for 
these experiments might be another reason why CD4-depleted T 
cells did not confer strong ear swelling. Furthermore, it is possible 
that CD8+ T cells became competent for the adoptive transfer of 
LS after in vitro sensitization with cLC in the presence of CD4+ T 
cells, as in the experiment with the whole T-cell fraction, but not 
when they were sensitized with cLC in the absence of CD4+ T 
cells. Experiments including separation of CD4+ T cells and CD8+ 
cells after sensitization and expansion but before transfer would 
answer this question. However, T-cell numbers required for 
such experiments (- 109 cells) in our system were not ob-
tained. 
How could the small response with CD4~depleted T cells be 
explained? Our protocol for purification ofT-cell subsets routinely 
yields T cells with no detectable contamination as assessed by flow 
cytometric analysis (data not shown). However, the analysis was 
done before culture. In experiment 2 (Fig 2), we also analyzed the 
cells before transfer but after culture. The CD4-depleted fraction 
contained 3.0% CD4+ cells. Thus, it cannot be decided whether the 
small contamination by CD4+ T cells or the CD8+ T cells alone 
were involved in the small response seen in animals that received 
CD4-depleted T cells. It is known that CD4/8 phenotype and 
functio n do not strictly correlate. In addition, in experiments with 
hapten-modified skin grafts, it has been shown that induction of CS 
is not restricted only by the class II MHC, but also by the class I 
MHC [19]. It is therefore possible that class 1- and/or class II-
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restricted CD8+ (lymphokine secreting?) T cel ls at low frequencies 
were involved in the small response observed with CD4-depleted 
cells. Alternatively, the 3% contamination with CD4+ cells could 
also be directly or, via help to th e CD8+ cells, indirectly account for 
this small response. 
To characterize the in vitro immunized CD4+ T cells, we re-
stimulated in vitro aliquots of cells that conferred CS in vivo. The 
lymphokines identified in the cu lture supernatant and the results 
from the direct inhibition experiments suggest that the cells pro-
duced mainly IL-2 but little or no detectable IL-4 . IL-2 seems to be a 
crucial mediator in TNP-induced delayed skin-swelling responses 
because elimination of IL-2 receptor bearing cells inhibited this 
response [43 ,44] . Our in vivo activated and expanded CD8-de-
pleted T cells resemble CD4+ T-cell clones of type 1 as defined by 
Mossman and colleagues [45,46] in 2 points. Type 1 T helper cells 
also produce IL-2 but not IL-4 and may mediate a delayed inflamma-
tory reaction after adoptive transfer [31 ,47]. However, as defined by 
Mossman, they are long-term cultured and cloned T-cell lines de-
rived from conventionally immunized mice, have been shown to be 
active in a local adoptive transfer assay and possess a stable pheno-
type. On the contrary, our CD8-depleted T cells were sensitized in 
vitro with cLC and have not been tested in a local adoptive footpad 
swel ling assay. In addition, the lymphokine profile of our cells is not 
stable because repeated stimulation leads to th e establishment of 
CD4+ T cell lines that produce IL-4 and thus resemble type 2 T 
helper cells [22]. Type 1 T helper cell clones might represent a 
"frozen" differentiation stage ofT cells that mediate inflammatory 
phenomena in contrast to our cells, which lose this phenotype when 
repeatedly stimulated in vitro. The question of whether type-2-
like T helper cells may derive from type-l-like T helper cells 
remains to be answered. 
In summary, this paper demonstrates that the co-culture of hap-
ten-modified cLC and CD8-depleted T cells from naive mice fol-
lowed by expansion with IL-2 leads to type 1-like T helper cells , 
which produce IL-2 and mediate CS when injected into naive mice. 
This T -cell phenotype is lost upon subseguent culture. It remains to 
be shown whether loss of type l-like T helper cells plays a role in 
the down-regulation of allergic CS. 
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